Regarding loperamide use in patients with C. difficile infection, which statement is true?

• A. It slows colonic motility and prolongs exposure to toxin
• B. It prevents C. difficile infection
• C. It has no effect on C. difficile
• D. It is contraindicated in all diarrhea

Answer: (A)

Loperamide slows colonic motility by acting on opioid receptors in the gut, which reduces stool frequency and lengthens contact time of luminal contents with the colonic mucosa. In a C. difficile infection, the disease process is driven by toxins that damage the colon lining. If transit is slowed, more time is available for those toxins to interact with the mucosa, potentially worsening inflammation and increasing the risk of complications like ileus or toxic megacolon. That’s why loperamide can be harmful in this setting and is not recommended for suspected C. difficile infection. It does not prevent the infection, it can influence toxin exposure, and its blanket contraindication for all diarrhea is not accurate; in infectious diarrhea, especially with suspected C. difficile, it’s best to avoid it and treat with appropriate antibiotics and supportive care.